BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer

Overview of attention for article published in Scientific Reports, December 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

So far, Altmetric has seen 12 X posts from 12 X users, with an upper bound of 41,917 followers.

RT @FundacionFICMAC: BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer. https://t.co/ja…

BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer. https://t.co/javDXODsDt

BIM and mTOR expression levels predict outcome to #erlotinib in #LungCancer: https://t.co/HwVJ5DFeFr

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 8 additional X posts.